Every SEC Form 3/4/5 on record for this filer (CIK 1250195) — 12 issuers, 37 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS, INC. | Director | 2016-02-01 → 2026-03-09 | 18 | −$18M |
| MRKR | Marker Therapeutics, Inc. | Director | 2019-08-08 → 2025-11-19 | 10 | $2M |
| ELEV | Elevation Oncology, Inc. | Director | 2021-06-24 → 2025-07-24 | 8 | — |
| ZSAN | Zosano Pharma Corp | Director · lapsed | 2018-04-09 → 2021-06-14 | 9 | — |
| SNSS | SUNESIS PHARMACEUTICALS INC | 10% owner · lapsed | 2019-01-24 → 2019-07-15 | 2 | — |
| LOXO | Loxo Oncology, Inc. | Director · lapsed | 2015-07-30 → 2019-02-15 | 13 | −$38M |
| SYRS | Syros Pharmaceuticals, Inc. | 10% owner · lapsed | 2016-06-29 → 2016-07-06 | 2 | — |
| AGRX | AGILE THERAPEUTICS INC | 10% owner · lapsed | 2016-06-03 → 2016-06-03 | 1 | — |
| PTX | PERNIX THERAPEUTICS HOLDINGS, INC. | Director · lapsed | 2015-08-18 → 2016-05-31 | 2 | — |
| VRAY | ViewRay, Inc. | 10% owner · lapsed | 2016-03-30 → 2016-03-30 | 1 | — |
| TRXC | TRANSENTERIX INC. | Filer · lapsed | 2016-02-05 → 2016-02-05 | 1 | — |
| TTOO | T2 Biosystems, Inc. | Director · lapsed | 2015-12-09 → 2015-12-09 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ADMA | 2026-03-06 | Buy | 7,000 | $15.39 | $107,730 | 2,045,730 |
| ADMA | 2026-03-05 | Buy | 7,000 | $15.67 | $109,690 | 2,038,730 |
| ADMA | 2025-06-16 | Sell | 194,749 | $20.24 | $4M | 87,330 |
2 of 12 issuers are covered and open a security page; the rest are on file here only.
